Оценка трансфекции гена VEGF121 в мультипотентные стромальные клетки человека невирусными методами
Диссертация
В работе использовали центрифуги Eppendorf (Германия) и Jouan (Франция) — инвертированный микроскоп Olympus (Япония) — С02-инкубатор RS Biotech (New Brunswick Scientific, Великобритания) — морозильники Liebherr (Германия) и Sanyo (Япония) — автоматические пипетки и дозаторы Eppendorf (Германия), Ленпипет (Россия) — электропоратор Eppendorf (Германия) — термостаты BioSan (Латвия) и Binder… Читать ещё >
Список литературы
- Авдеева С. В. Создание рекомбинантных аденовирусов, экспрессирующих гены факторов роста кровеносных сосудов и изучение влияния этих вирусов на ангиогенез in vivo: Дис.. канд. биол. наук. Москва. 2005.-141 с.
- Биология стволовых клеток и клеточные технологии в 2 т. Под ред. Пальцева М. А. М.: Медицина, 2009, 728 с.
- Бочков Н. П. Клеточная терапия в свете доказательной медицины // Клиническая медицина. 2006. — Т. 3, № 10. — с. 4−10.
- Бочков Н. П., Воронов Д. А. Генотерапия в лечении сердечнососудистых заболеваний: фундаментальные основы, терапевтический потенциал, современное состояние и перспективы // Кардиология и сердечно-сосудистая хирургия. — 2010. Т. 3, № 3. — с. 4−11.
- Бочков Н. П., Никитина В. А., Рослова Т. А., Чаушев И. Н., Якушина И. И. Клеточная терапия наследственных болезней // Вестник РАМН. 2008. — № 10. — с. 20−28.
- Кочегура Т. Н., Ефименко А. Ю., Акопян Ж. А., Парфенова Е. Е. Клеточная терапия сердечной недостаточности: клинический опыт, проблемы и перспективы // Клеточная трансплантология и тканевая инженерия. 2010. — Т. V, № 2. — с. 11−18.
- Парфенова Е. В., Ткачук В. А. Перспективы генной терапии сердечно-сосудистых заболеваний // Вопросы медицинской химии. 2000. Т. 46, № 3.- с. 293−310.
- Al-Khaldi A., Al-Sabti Н., Galipeau J., Lachapelle К. Therapeutic angiogenesis using autologous bone marrow stromal cells: improved blood flow in a chronic limb ischemia model // Ann Thorac Surg. 2003. — № 75. — p. 204 209.
- Bahadori M. New Advances in RNAs // Arch Iranian Med. 2008. -№ 11(4).-p. 435−443.
- Baksh D., Yao R., Tuan R. S. Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow // Stem Cells. 2007. — № 25(6). — p. 1384−1392.
- Balyasnikova I. V., Franco-Gou R., Mathis J. M., Lesniak M. S. Genetic modification of mesenchymal stem cells to express a single-chain antibody against EGFRvIII on the cell surface // J Tissue Eng Regen Med. -2009. Article online.
- Bangari D. S., Mittal S. K. Current strategies and future directions for eluding adenoviral vector immunity // Curr Gene Ther. 2006. — № 6. — p. 215 226.
- Bestor T. H. Gene silencing as a threat to the success of gene therapy // J Clin Invest. 2000. — № 105. — p. 409−411.81
- Bosch P., Pratt S. L., Stice S. L. Isolation, Characterization, Gene Modification, and Nuclear Reprogramming of Porcine Mesenchymal Stem Cells // Biology of Reproduction. 2006. — № 1 (vol. 74). — p. 46−57.
- Bushman F., Lewinski M., Ciuffi A., Barr S., Leipzig J., Hannenhalli S., Hoffmann C. Genome-wide analysis of retroviral DNA integration // Nat Rev Microbiol. 2005. -№ 3. — p. 848−858.
- Cao F., Xie X., Gollan T., Zhao L., Narsinh K., Lee R. J., Wu J. C. Comparison of gene-transfer efficiency in human embryonic stem cells // Mol Imaging Biol.- 2010. -№ 12(1).-p. 15−24.
- Chan J., O’Donoghue K., de la Fuente J., Roberts I. A., Kumar S., Morgan J. E., Fisk N. M. Human fetal mesenchymal stem cells as vehicles for gene delivery // Stem Cells. 2005. — № 23. — p. 93−102.
- Chelobanov B. P., Laktionov P. P., Vlasov V. V. Proteins involved in binding and cellular uptake of nucleic acids // Biochemistry (Mosc). 2006. -№ 71 (6).-p. 583−596.
- Cheng J. C., Matsen C. B., Gonzales F. A., Ye W., Greer S., Marquez V. E., Jones P. A., Selker E. U. Inhibition of DNA methylation and reactivation of silenced genes by zebularine // J. Natl. Cancer Inst. 2003. — № 95. — p. 399 409.
- Cheng L., Ziegelhoffer P. R., Yyang N-S. In vivo promoter activity and transgene expression in mammalian somatic tissues evaluated by usingparticle bombardment // Proc. Natl. Acad. Sci. USA. 1993. — Vol. 90. — c. 4455−4459.
- Cheng T., Xu C. Y, Wang Y. B., Chen M., Wu T., Zhang J., Xia N. S. A rapid and efficient method to express target genes in mammalian cells by baculovirus // World J Gastroenterol. 2004. — № 10 (11). — p. 1612−1618.
- Christiano R. Viral and non-viral vectors for cancer gene therapy // Anticancer Res. 1998. — № 18. — p. 3142−3246.
- Cohen R. N., van der Aa M. A. E. M., Macaraeg N., Lee A. P., Szoka F. C. Jr. Quantification of Plasmid DNA Copies in the Nucleus after Lipoplex and Polyplex Transfection // J Control Release. 2009. — 135(2). — p. 166−174.
- Cudkowicz G., Upton A. C., Smith L. H.5 Gosslee D. G., Hughes W. L. An Approach to the Characterization of Stem Cells in Mouse Bone Marrow // Ann N Y Acad Sci. 1964. — № 114. — p. 571−585.
- Di Ianni M., Terenzi A., Perruccio K., Ciurnelli R., Lucheroni F., Benedetti R., Martelli M. F., Tabilio A. 5-Azacytidine prevents transgene methylation in vivo // Gene Therapy. 1999. — № 4(6). — p. 703−707.
- Engler C., Kelliher C., Wahlin K. J., Speck C. L., Jun A. S. Comparison of non-viral methods to genetically modify and enrich populations of primary human corneal endothelial cells // Mol Vis. 2009. — № 15. — p. 629 637.
- Escher G., Hoang A., Georges S., Tchoua U., El-Osta A., Krozowski Z., Sviridov D. Demethylation using the epigenetic modifier, 5-azacytidine, increases the efficiency of transient transfection of macrophages // J. Lipid Res. 2005. — № 46. — p. 356−365.
- Fazzari M. J., Greally J. M. Epigenomics: beyond CpG islands. // Nat. Rev.Genet. 2004. — № 5. — p. 44655.
- Finnin M. S., Donigian J. R., Cohen A., Richon V. M., Rifkind R. A., Marks P. A., Breslow R., Pavletich N. P. Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors // Nature. 1999. — № 401. -p. 188−193.
- Flotte T. R. Gene therapy: The first two decades and the current state-of-the-art // J Cell Physiol. 2007. — № 213. — p. 301−305.
- Gaetano C., Catalano A., Palumbo R., Illi B., Orlando G., Ventoruzzo G., Serino F., Capogrossi M. C. Transcriptionally active drugs improve adenovirus vector performance in vitro and in vivo // Gene Therapy. — 2000. — № 7.-p. 1624−1630.
- Gaymalov Z. Z., Yang Z., Pisarev V. M., Alakhov V. Y., Kabanov A. V. The effect of the nonionic block copolymer pluronic P85 on gene expression in mouse muscle and antigen-presenting cells // Biomaterials. 2009. — 30(6). -p. 1232−45.
- Gheisari Y., Soleimani M., Azadmanesh K., Zeinali S. Multipotent mesenchymal stromal cells: optimization and comparison of five cationic polymer-based gene delivery methods // Cytotherapy. 2008. — 10(8). — p. 81 523.
- Gottfried O. N., Dailey A. T. Mesenchymal Stem Cell And Gene Therapies For Spinal Fusion // Neurosurgery. 2008. — № 63. — p. 380−392.
- Gwak, S. J., Kim, B. S. Poly (lactic-co-glycolic acid) nanosphere as a vehicle for gene delivery to human cord blood-derived mesenchymal stem cells: comparison with polyethylenimine // Biotechnol Lett. 2008. — № 30(7). — p. 1177−1182.
- Haleem-Smith H., Derfoul A., Okafor C., Tuli R., Olsen D., Hall D. J., Tuan R. S. Optimization of high-efficiency transfection of adult human mesenchymal stem cells in vitro // Mol Biotechnol. 2005. — № 30. — p. 9−20.
- Hamm A., Krott N., Breibach I., Blindt R., Bosserhoff A. K. Efficient transfection method for primary cells // Tissue Eng. 2002. — № 8. — p. 235 245.
- He J., Yang Q., Chang L. J. Dynamic DNA methylation and histone modifications contribute to lentiviral transgene silencing in murine embryonic carcinoma cells // J Virol. 2005. — № 79(21). — p. 13 497−13 508.85
- Helledie T., Nurcombe V., Cool S. M. A simple and reliable electroporation method for human bone marrow mesenchymal stem cells // Stem Cells Dev. 2008. — № 17(4). — p. 837−848.
- Hung S.-C., Lu C.-Y., Shyue S.-K., Liu H.-C., Hob L. L.-T. Lineage Differentiation-Associated Loss of Adenoviral Susceptibility and Coxsackie-Adenovirus Receptor Expression in Human Mesenchymal Stem Cells // Stem Cells.-2004.-№ 22.-p. 1321−1329.
- Iversen N., Birkenes B., Torsdalen K., Djurovic S. Electroporation by nucleofector is the best nonviral transfection technique in human endothelial and smooth muscle cells // Genet Vaccines Ther. 2005. — № 3(1). — p. 2.
- Jones P. A., Taylor S. M. Cellular differentiation, cytidine analogs and DNA methylation // Cell. 1980. — № 20. — p. 85−93.
- Kaigier D., Krebsbach P. H, Polverini P. J, Mooney D. J. Role of vascular endothelial growth factor in bone marrow stromal cell modulation of endothelial cells //Tissue Eng. -2003. -№ 9(1). p. 95−103.
- Kameda T., Smuga-Otto K., Thomson J. A. A severe de novo methylation of episomal vectors by human ES cells // Biochemical and Biophysical Research Communications. 2006. — № 349. — p. 1269−1277.
- Kim J. H., Park S. N., Suh H. Generation of insulin-producing human mesenchymal stem cells using recombinant adeno-associated virus // Yonsei Med J. 2007. — № 48(1). — p. 109−119.
- Kucerova L., Altanerova V., Matuskova M., Tyciakova S., Altaner C. Adipose Tissue-Derived Human Mesenchymal Stem Cells Mediated Prodrug Cancer Gene Therapy // Cancer Research. — 2007. № 67. — p. 6304−6313.
- Lakshmipathy U., Pelacho B., Sudo K., Linehan J. L., Coucouvanis
- E., Kaufman D. S., Verfaillie C. M. Efficient transfection of embryonic and adult stem cells // Stem Cells. 2004. -№ 22. — p. 531−543.
- Le Blanc K., Rasmusson I., Sundberg B., Gotherstrom C., Hassan M., Uzunel M., Ringden O. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells // Lancet. — 2004. — № 363. — p. 1439−1441.
- Lee J. B., Bae Y. C., Sung S. M., Jung J. S. Human adipose tissue-derived mesenchymal stem cells improve postnatal neovascularization in a mouse model of hindlimb ischemia // Cell Physiol Biochem. 2006. — № 17(5−6).-p. 279−290.
- Lee K., Majumdar M. K., Buyaner D., Hendricks J. K., Pittenger M.
- F., Mosca J. D. Human mesenchymal stem cells maintain trangene expression during expansion and differentiation // Mol Ther. 2001. — № 3. — p. 857−866.
- Ma L., Wang G., Li L., Feng K., Bai L., Pei X. Expression of lipofect AMINE mediated human GM-CSF eukaryotic expressing vector in HFCL cells // Zhonghua Xue Ye Xue Za Zhi. 2000. — № 21(12). p. 624−627.
- Madonna R., Willerson J. T., Geng Y. J. Myocardin a enhances telomerase activities in adipose tissue mesenchymal cells and embryonic stem cells undergoing cardiovascular myogenic differentiation // Stem Cells. — 2008. -№ 26(1).-p. 202−211.
- Majumdar M. K., Thiede M. A., Mosca J. D., Moorman M., Gerson S. L. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells // J. Cell. Physiol. 1998. -№ 176.-p. 57−66.
- Makino S., Fukuda K., Miyoshi S., Konishi F., Kodama H., Pan J., Sano M., Takahashi T., Hori S., Abe H., Hata J., Umezawa A., Ogawa S. Cardiomyocytes can be generated from marrow stromal cells in vitro // J Clin Invest. 1999. -№ 103(5). — p. 697−705.
- Marshall H. M., Ronen K., Berry C., Llano M., Sutherland H., Saenz D., Bickmore W., Poeschla E., Bushman F. D. Role of PSIPl/LEDGF/p75 in Lentiviral Infectivity and Integration Targeting // PLoS ONE. 2007. — № 2. -p. el340.
- Mclnerney J. M., Nawrocki J. R., Lowrey C.H. Long-term silencing of retroviral vectors is resistant to reversal by trichostatin A and 5-azacytidine // Gene Ther. 2000. — № 7. — p. 653−663. '
- Mei S. H., McCarter S. D., Deng Y., Parker C. H., Liles W. C., Stewart D. J. Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1 // PLoS Med. 2007. -№ 4(9).-p. e269.
- Meng Q.Y., Li X.Q., Yu X.B., Lei F. R., Jiang K., Li C. Y. Transplantation of VEGF165-gene-transfected endothelial progenitor cells in the treatment of chronic venous thrombosis in rats // Chin Med J (Engl). — 2010. — № 123 (4).-p. 471−477.
- Modlich U., Baum C. Preventing and exploiting the oncogenic potential of integrating gene vectors // J Clin Invest. 2009. — № 119(4). — p. 755−758.
- Mok P. L., Cheong S. K., Leong C. F., Othman A. In vitro expression of erythropoietin by transfected human mesenchymal stromal cells // Cytotherapy. 2008. — № 10(2). — p. 116−124.
- Morozkin E. S., Laktionov P. P., Rykova E. Y., Vlassov V. V. Extracellular nucleic acids in cultures of long-term cultivated eukaryotic cells // Ann N Y Acad Sei. 2004. — № 1022. — p. 244−249.90
- Naldini L., Blomer U., Gallay P., Ory D., Mulligan R., Gage F. H., Verma I. M., Trono D. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector // Science. 1996. — № 272(5259). — p. 263−267.
- Nan X., Campoy F. J., Bird A. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin // Cell. 1997. — № 88. — p. 471−481.
- Palmer G. D., Steinert A., Pascher A., Gouze E., Gouze J. N., Betz O., Johnstone B., Evans C. H., Ghivizzani S, C. Gene-induced chondrogenesis of primary mesenchymal stem cells in vitro // Mol Ther. 2005. — № 12(2). — p. 219−228.
- Parolin C., Sodroski J. A defective HIV-1 vector for gene transfer to human lymphocytes // J Mol Med. 1995. — № 73(6). — p. 279−288.
- Partridge K. A., Oreffo R. O. Gene delivery in bone tissue engineering: progress and prospects using viral and nonviral strategies // Tissue Eng. 2004. — № 10. — p. 295−307.
- Patkin E. L. Epigenetic mechanisms for primary differentiation in mammalian embryos // Int Rev Cytol. 2002. -№ 216. — p. 81−129.
- Paulsen M., Ferguson-Smith A. C. DNA methylation in genomic imprinting, development, and disease. // J Pathol. 2001. — № 195. — p. 97−110.
- Pitard B., Pollard H., Agbulut O., Lambert O., Vilquin J. T., Cherel91
- Y., Abadie J., Samuel J. L., Rigaud J. L., Menoret S., Anegon I., Escande D. A nonionic amphiphile agent promotes gene delivery in vivo to skeletal and cardiac muscles // Hum Gene Ther. 2002. — № 13(14). — p. 1767−75.
- Pittenger M. F., Mackay A. M., Beck S. C., Jaiswal R. K., Douglas R., Mosca J. D., Moorman M. A., Simonetti D. W., Craig S., Marshak D. R. Multilineage potential of adult human mesenchymal stem cells // Science. -1999. -№ 284. -p. 143−147.
- Praznovszky T., Kereso J., Tubak V., Cserpan I., Fatyol K., Hadlaczky G. De novo chromosome formation in rodent cells // Proc Natl Acad Sci USA. 1991. — № 88(24). — p. 11 042−11 046.
- Psaltis P. J., Zannettino A. C. W., Worthley S. G., Gronthosb S. Concise Review: Mesenchymal Stromal Cells: Potential for Cardiovascular Repair // Stem Cells. 2008. — № 26. — p. 2201−2210.
- Riew K. D., Wright N. M., Cheng S., Avioli L. V., Lou J. Induction of bone fonnation using a recombinant adenoviral vector carrying the human BMP-2 gene in a rabbit spinal fusion model // Calcif Tissue Int. 1998. — № 63(4).-p. 357−360.
- Rosenqvist N., Hard Af Segerstad C., Samuelsson C., Johansen J., Lundberg C. Activation of silenced transgene expression in neural precursor cell lines by inhibitors of histone deacetylation // J. Gene Med. 2002. — № 4. — p. 248−257.
- Sadan 0., Melamed E., Offen D. Bone-marrow-derived mesenchymal stem cell therapy for neurodegenerative diseases // Expert Opin Biol Ther. -2009. № 9(12). — p. 1487−1497.
- Schaffler A., Buchler C. Concise Review: Adipose Tissue-Derived Stromal Cells—Basic and Clinical Implications for Novel Cell-Based Therapies // Stem Cells. 2007. — № 25. — p. 818−827.
- Sheyn D., Pelled G., Zilberman Y., Talasazan F., Frank J. M., Gazit D., Gazit Z. Nonvirally engineered porcine adipose tissue-derived stem cells: use in posterior spinal fusion // Stem Cells. 2008. — № 26(4). — p. 1056−1064.
- Somia N., Verma I. M. Gene Therapy: Trials and Tribulations // Nature Reviews Genetics. 2000. -№ 1(2). — p. 91−99.
- Spizizen J., Reilly B. E., Evans A. H. Microbial transformation and transfection // Annu Rev Microbiol. 1966. — № 20. — p. 371−400.
- Sriadibhatla S., Yang Z., Gebhart C., Alakhov V. Y., Kabanov A. Transcriptional activation of gene expression by pluronic block copolymers in93stably and transiently transfected cells // Mol Ther. 2006. — 13(4). — p. 804−13.
- Stender S., Murphy M., O’Brien T., Stengaard C., Ulrich-Vinther M., Soballe K., Barry F. Adeno-associated viral vector transduction of human mesenchymal stem cells // Eur Cell Mater. 2007. -№ 13. — p. 93−99.
- Tate P., Skarnes W., Bird A. The methyl-CpG binding protein MeCP2 is essential for embryonic development in the mouse // Nat Genet. 1996. — № 12.-p. 205−208.
- Tichy P., Rytir V., Kohoutova M. Genetic transformation and transfection of Bacillus subtilis spheroplasts // Folia Microbiol (Praha). — 1968. -№ 13(6).-p. 510−514.
- Tu Q., Valverde P., Li S., Zhang J., Yang P., Chen J. Osterix overexpression in mesenchymal stem cells stimulates healing of critical-sized defects in murine calvarial bone // Tissue Eng. 2007. — № 13(10). — p. 24 312 440.
- Uchida E., Mizuguchi H., Ishii-Watabe A., Hayakawa T. Comparison of the efficiency and safety of non-viral vector-mediated gene transfer into a wide range of human cells // Biol Pharm Bull. 2002. — № 25. — p. 891−897.
- Valero A., Post J. N., van Nieuwkasteele J. W., Ter Braak P. M., Kruijer W., van den Berg A. Gene transfer and protein dynamics in stem cells using single cell electroporation in a microfluidic device // Lab Chip. 2008. -№ 8(1).-p. 62−67.
- Wu M. H., Liebowitz D. N., Smith S. L., Williams S. F., Dolan M.E. Efficient expression of foreign genes in human CD34(+) hematopoietic precursor cells using electroporation // Gene Ther. 2001. — № 8(5). — p. 384 390.
- Xu Y., Mirmalek-Sani S. H., Lin F., Zhang J., Oreffo R. O. Adipocyte differentiation induced using nonspecific siRNA controls in cultured human mesenchymal stem cells // RNA. 2007. — № 13(8). — p. 1179−1183.
- Yang J. F., Zhou W. W., Tang T., Hu J. G., Yu J. F., Yang Y. F., Zhou X. M., Hu D. X. Transfection of human VEGF165 gene into bone marrow mesenchymal stem cells in rats // Zhong Nan Da Xue Xue Bao Yi Xue Ban. — 2006. № 31(3). — p. 313−318.
- Yoshimura K., Sato K., Aoi N., Kurita M., Hirohi T., Harii K. Cell-Assisted Lipotransfer for Cosmetic Breast Augmentation: Supportive Use of Adipose-Derived Stem/Stromal Cells // Aesth Plast Surg. 2008. — № 32. — p. 48−55.
- Zeng B., Chen H.5 Zhu C., Ren X., Lin G., Cao F. Effects of combined mesenchymal stem cells and heme oxygenase-1 therapy on cardiac performance // Eur J Cardiothorac Surg. 2008. — № 34(4). p. 850−856.
- Zhang X. Y., La Russa V. F., Bao L., Kolls J., Schwarzenberger P., Reiser J. Lentiviral vectors for sustained transgene expression in human bone marrow-derived stromal cells // Mol Ther. 2002. — № 5. — p. 555−565.
- Zhang X.-Y., La Russa V.F., Reiser J. Transduction of Bone-Marrow-Derived Mesenchymal Stem Cells by Using Lentivirus Vectors Pseudotyped with Modified RD114 Envelope Glycoproteins // Journal of Virology. 2004. -№ 3 (78). — p. 1219−1229.